182 related articles for article (PubMed ID: 36007890)
1. Cullin 3 mutant causing familial hyperkalemic hypertension lacks normal activity in the kidney.
Maeoka Y; Cornelius RJ; Ferdaus MZ; Sharma A; Nguyen LT; McCormick JA
Am J Physiol Renal Physiol; 2022 Nov; 323(5):F564-F576. PubMed ID: 36007890
[TBL] [Abstract][Full Text] [Related]
2. Combined Kelch-like 3 and Cullin 3 Degradation is a Central Mechanism in Familial Hyperkalemic Hypertension in Mice.
Maeoka Y; Ferdaus MZ; Cornelius RJ; Sharma A; Su XT; Miller LN; Robertson JA; Gurley SB; Yang CL; Ellison DH; McCormick JA
J Am Soc Nephrol; 2022 Mar; 33(3):584-600. PubMed ID: 35064051
[TBL] [Abstract][Full Text] [Related]
3. Mutant Cullin 3 causes familial hyperkalemic hypertension via dominant effects.
Ferdaus MZ; Miller LN; Agbor LN; Saritas T; Singer JD; Sigmund CD; McCormick JA
JCI Insight; 2017 Dec; 2(24):. PubMed ID: 29263298
[TBL] [Abstract][Full Text] [Related]
4. Hyperkalemic hypertension-associated cullin 3 promotes WNK signaling by degrading KLHL3.
McCormick JA; Yang CL; Zhang C; Davidge B; Blankenstein KI; Terker AS; Yarbrough B; Meermeier NP; Park HJ; McCully B; West M; Borschewski A; Himmerkus N; Bleich M; Bachmann S; Mutig K; Argaiz ER; Gamba G; Singer JD; Ellison DH
J Clin Invest; 2014 Nov; 124(11):4723-36. PubMed ID: 25250572
[TBL] [Abstract][Full Text] [Related]
5. Degradation by Cullin 3 and effect on WNK kinases suggest a role of KLHL2 in the pathogenesis of Familial Hyperkalemic Hypertension.
Zhang C; Meermeier NP; Terker AS; Blankenstein KI; Singer JD; Hadchouel J; Ellison DH; Yang CL
Biochem Biophys Res Commun; 2016 Jan; 469(1):44-48. PubMed ID: 26607111
[TBL] [Abstract][Full Text] [Related]
6. Renal effects of cullin 3 mutations causing familial hyperkalemic hypertension.
Cornelius RJ; Maeoka Y; McCormick JA
Curr Opin Nephrol Hypertens; 2023 Jul; 32(4):335-343. PubMed ID: 37070483
[TBL] [Abstract][Full Text] [Related]
7. Renal COP9 Signalosome Deficiency Alters CUL3-KLHL3-WNK Signaling Pathway.
Cornelius RJ; Si J; Cuevas CA; Nelson JW; Gratreak BDK; Pardi R; Yang CL; Ellison DH
J Am Soc Nephrol; 2018 Nov; 29(11):2627-2640. PubMed ID: 30301860
[TBL] [Abstract][Full Text] [Related]
8. ROMK expression remains unaltered in a mouse model of familial hyperkalemic hypertension caused by the CUL3Δ403-459 mutation.
Murthy M; Kurz T; O'Shaughnessy KM
Physiol Rep; 2016 Jul; 4(13):. PubMed ID: 27378813
[TBL] [Abstract][Full Text] [Related]
9. Dual gain and loss of cullin 3 function mediates familial hyperkalemic hypertension.
Cornelius RJ; Zhang C; Erspamer KJ; Agbor LN; Sigmund CD; Singer JD; Yang CL; Ellison DH
Am J Physiol Renal Physiol; 2018 Oct; 315(4):F1006-F1018. PubMed ID: 29897280
[TBL] [Abstract][Full Text] [Related]
10. Novel
Chatrathi HE; Collins JC; Wolfe LA; Markello TC; Adams DR; Gahl WA; Werner A; Sharma P
Hypertension; 2022 Jan; 79(1):60-75. PubMed ID: 34878901
[TBL] [Abstract][Full Text] [Related]
11. Characterisation of the Cullin-3 mutation that causes a severe form of familial hypertension and hyperkalaemia.
Schumacher FR; Siew K; Zhang J; Johnson C; Wood N; Cleary SE; Al Maskari RS; Ferryman JT; Hardege I; Yasmin ; Figg NL; Enchev R; Knebel A; O'Shaughnessy KM; Kurz T
EMBO Mol Med; 2015 Oct; 7(10):1285-306. PubMed ID: 26286618
[TBL] [Abstract][Full Text] [Related]
12. Mutation affecting the conserved acidic WNK1 motif causes inherited hyperkalemic hyperchloremic acidosis.
Louis-Dit-Picard H; Kouranti I; Rafael C; Loisel-Ferreira I; Chavez-Canales M; Abdel-Khalek W; Argaiz ER; Baron S; Vacle S; Migeon T; Coleman R; Do Cruzeiro M; Hureaux M; Thurairajasingam N; Decramer S; Girerd X; O'Shaugnessy K; Mulatero P; Roussey G; Tack I; Unwin R; Vargas-Poussou R; Staub O; Grimm R; Welling PA; Gamba G; Clauser E; Hadchouel J; Jeunemaitre X
J Clin Invest; 2020 Dec; 130(12):6379-6394. PubMed ID: 32790646
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms and controversies in mutant Cul3-mediated familial hyperkalemic hypertension.
Ferdaus MZ; McCormick JA
Am J Physiol Renal Physiol; 2018 May; 314(5):F915-F920. PubMed ID: 29361671
[TBL] [Abstract][Full Text] [Related]
14. Role of KLHL3 and dietary K
Ostrosky-Frid M; Chávez-Canales M; Zhang J; Andrukhova O; Argaiz ER; Lerdo-de-Tejada F; Murillo-de-Ozores A; Sanchez-Navarro A; Rojas-Vega L; Bobadilla NA; Vazquez N; Castañeda-Bueno M; Alessi DR; Gamba G
Am J Physiol Renal Physiol; 2021 May; 320(5):F734-F747. PubMed ID: 33682442
[TBL] [Abstract][Full Text] [Related]
15. Disruption of CUL3-mediated ubiquitination causes proximal tubule injury and kidney fibrosis.
Saritas T; Cuevas CA; Ferdaus MZ; Kuppe C; Kramann R; Moeller MJ; Floege J; Singer JD; McCormick JA
Sci Rep; 2019 Mar; 9(1):4596. PubMed ID: 30872636
[TBL] [Abstract][Full Text] [Related]
16. The CUL3-KLHL3 E3 ligase complex mutated in Gordon's hypertension syndrome interacts with and ubiquitylates WNK isoforms: disease-causing mutations in KLHL3 and WNK4 disrupt interaction.
Ohta A; Schumacher FR; Mehellou Y; Johnson C; Knebel A; Macartney TJ; Wood NT; Alessi DR; Kurz T
Biochem J; 2013 Apr; 451(1):111-22. PubMed ID: 23387299
[TBL] [Abstract][Full Text] [Related]
17. Severe Arterial Hypertension from Cullin 3 Mutations Is Caused by Both Renal and Vascular Effects.
Abdel Khalek W; Rafael C; Loisel-Ferreira I; Kouranti I; Clauser E; Hadchouel J; Jeunemaitre X
J Am Soc Nephrol; 2019 May; 30(5):811-823. PubMed ID: 30967423
[TBL] [Abstract][Full Text] [Related]
18. Hypertension-causing cullin 3 mutations disrupt COP9 signalosome binding.
Cornelius RJ; Yang CL; Ellison DH
Am J Physiol Renal Physiol; 2020 Jan; 318(1):F204-F208. PubMed ID: 31813255
[TBL] [Abstract][Full Text] [Related]
19. Insights into the diverse mechanisms and effects of variant CUL3-induced familial hyperkalemic hypertension.
Sharma P; Chatrathi HE
Cell Commun Signal; 2023 Oct; 21(1):286. PubMed ID: 37845702
[TBL] [Abstract][Full Text] [Related]
20. Cullin 3 and Blood Pressure Regulation: Insights From Familial Hyperkalemic Hypertension.
Maeoka Y; Cornelius RJ; McCormick JA
Hypertension; 2023 May; 80(5):912-923. PubMed ID: 36861484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
